11-66600548-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_005125.2(CCS):c.488G>T(p.Arg163Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000441 in 1,360,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R163W) has been classified as Likely benign.
Frequency
Consequence
NM_005125.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCS | NM_005125.2 | c.488G>T | p.Arg163Leu | missense_variant, splice_region_variant | 5/8 | ENST00000533244.6 | NP_005116.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCS | ENST00000533244.6 | c.488G>T | p.Arg163Leu | missense_variant, splice_region_variant | 5/8 | 1 | NM_005125.2 | ENSP00000436318 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000441 AC: 6AN: 1360044Hom.: 0 Cov.: 26 AF XY: 0.00000444 AC XY: 3AN XY: 676124
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | The c.488G>T (p.R163L) alteration is located in exon 5 (coding exon 5) of the CCS gene. This alteration results from a G to T substitution at nucleotide position 488, causing the arginine (R) at amino acid position 163 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at